Upper Limb Spinal Cord Stimulation for Rehabilitation Enhancement
- Disease/Condition
- Spinal Cord Injuries
- Drug/Device/Intervention
- Transcutaneous spinal cord stimulation added to inpatient rehabilitation
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- University College, London
- Location
- London, United Kingdom
- Phase
- N/A
- Start date
- Jun 28, 2023
- End date
- Apr 16, 2025
- Enrollment
- 6 participants
Change in International Standards of Neurological Classification for SCI (ISNC-SCI).
In the United Kingdom, there are more than 1000 new cases of spinal cord injury (SCI) each
 year, with around half of these injuries affecting the cervical spine. People who have
 reduced function and control affecting their upper limbs may have difficulty carrying out
 activities of daily living (ADLs), significantly affecting their independence. Recovering
 even partial upper limb function is a top priority among tetraplegics.
 
 Regaining voluntary function in the upper limb can have a huge impact on quality of life.
 Using TSCS in the upper limb for acute SCI can benefit patients early in their
 rehabilitation, and may reduce the number of patients with problematic spasticity at
 discharge. Transcutaneous spinal cord stimulation (TSCS) may provide a low-cost method of
 improving function and spasticity in this cohort.
 
 We are investigating the effect of adding non-invasive SCS to inpatient rehabilitation on
 upper limb function for people with acute SCI. We will test this by randomly assigning
 volunteers to either a control group, who will receive their normal inpatient rehabilitation
 only, and an intervention group, who will have non-invasive SCS added to their normal
 inpatient rehabilitation, targeting their upper limbs.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05991804
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05991804 through Pure Global AI's free database. This phase not specified trial is sponsored by University College, London and is currently Recruiting. The study focuses on Spinal Cord Injuries. Target enrollment is 6 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.